The controlled presentation of TGF-β1 to hepatocytes in a 3D-microfluidic cell culture system

Biomaterials

Volumn 30, Issue 23-24, 2009, Pages 3847-3853

  Zhang, Chi ^a,b   Chia, Ser Mien ^c   Ong, Siew Min ^a,b   Zhang, Shufang ^a,d   Toh, Yi Chin ^a   van Noort, Danny ^a   Yu, Hanry ^a,b,c,d,e,f  

^a INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d Centre for Life Sciences   (Singapore)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^f Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

3D cell constructs; Controlled release; Hepatocyte co culture; Microfluidics; Soluble microenvironment; Transforming growth factor

Indexed keywords

3D CELL CONSTRUCTS; CONTROLLED RELEASE; HEPATOCYTE CO-CULTURE; SOLUBLE MICROENVIRONMENT; TRANSFORMING GROWTH FACTOR;

BIOACTIVITY; MICROFLUIDICS; PEPTIDES; THREE DIMENSIONAL;

CELL CULTURE;

ALBUMIN; GELATIN; MICROSPHERE; PARACETAMOL; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME IMMOBILIZATION; IN VITRO STUDY; LIVER CELL CULTURE; LIVER FUNCTION; LIVER TOXICITY; MALE; MICROFLUIDICS; NONHUMAN; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; GELATIN; HEPATOCYTES; MICROFLUIDICS; MICROSCOPY, ATOMIC FORCE; MICROSPHERES; RATS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 67349277662     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.03.052     Document Type: Article

References (34)

1. Guilluozo A.M.F., Langouet S., Maheo K., and Rissel M. Use of hepatocyte cultures for the study of hepatotoxic compounds. J Hepatol 26 Suppl. 2 (1997) 73-80
2. Kim Y.S., Kim J.S., Cho H.S., Rha D.S., Kim J.M., Park J.D., et al. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 20 6 (2008) 575-583
3. Boess F., Kamber M., Romer S., Gasser R., Muller D., Albertini S., et al. Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems. Toxicol Sci 73 2 (2003) 386-402
4. Kemp D.C., and Brouwer K.L. Viability assessment in sandwich-cultured rat hepatocytes after xenobiotic exposure. Toxicol In Vitro 18 6 (2004) 869-877
5. Davis M.W., and Vacanti J.P. Toward development of an implantable tissue engineered liver. Biomaterials 17 3 (1996) 365-372
6. Allen J.W., and Bhatia S.N. Engineering liver therapies for the future. Tissue Eng 8 5 (2002) 725-737
7. Streetz K.L. Bio-artificial liver devices - tentative, but promising progress. J Hepatol 48 2 (2008) 189-191
8. Gerlach J.C. Use of hepatocyte cultures for liver support bioreactors. Adv Exp Med Biol 368 (1994) 165-171
9. Gomez-Lechon M.J., Donato M.T., Castell J.V., and Jover R. Human hepatocytes as a tool for studying toxicity and drug metabolism. Curr Drug Metab 4 4 (2003) 292-312
10. Toh Y.C., Zhang C., Zhang J., Khong Y.M., Chang S., Samper V.D., et al. A novel 3D mammalian cell perfusion-culture system in microfluidic channels. Lab Chip 7 3 (2007) 302-309
11. Vekemans K., and Braet F. Structural and functional aspects of the liver and liver sinusoidal cells in relation to colon carcinoma metastasis. World J Gastroenterol 11 33 (2005) 5095-5102
12. Dittrich P.S., and Manz A. Lab-on-a-chip: microfluidics in drug discovery. Nat Rev Drug Discov 5 3 (2006) 210-218
13. Washizu J., Berthiaume F., Mokuno Y., Tompkins R.G., Toner M., and Yarmush M.L. Long-term maintenance of cytochrome P450 activities by rat hepatocyte/3T3 cell co-cultures in heparinized human plasma. Tissue Eng 7 6 (2001) 691-703
14. Seo S.J., Kim I.Y., Choi Y.J., Akaike T., and Cho C.S. Enhanced liver functions of hepatocytes cocultured with NIH 3T3 in the alginate/galactosylated chitosan scaffold. Biomaterials 27 8 (2006) 1487-1495
15. Bhatia S.N., Yarmush M.L., and Toner M. Controlling cell interactions by micropatterning in co-cultures: hepatocytes and 3T3 fibroblasts. J Biomed Mater Res 34 2 (1997) 189-199
16. Nahmias Y., Berthiaume F., and Yarmush M.L. Integration of technologies for hepatic tissue engineering. Adv Biochem Eng Biotechnol 103 (2007) 309-329
17. Chia S.M., Lin P.C., and Yu H. TGF-beta1 regulation in hepatocyte-NIH3T3 co-culture is important for the enhanced hepatocyte function in 3D microenvironment. Biotechnol Bioeng 89 5 (2005) 565-573
18. Wakefield L.M., Winokur T.S., Hollands R.S., Christopherson K., Levinson A.D., and Sporn M.B. Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution. J Clin Invest 86 6 (1990) 1976-1984
19. Catelas I., Dwyer J.F., and Helgerson S. Controlled release of bioactive transforming growth factor beta-1 from fibrin gels in vitro. Tissue Eng Part C Methods 14 2 (2008) 119-128
20. Ong S.M., Zhang C., Toh Y.C., Kim S.H., Foo H.L., Tan C.H., et al. A gel-free 3D microfluidic cell culture system. Biomaterials 29 22 (2008) 3237-3244
21. Chia S.M., Leong K.W., Li J., Xu X., Zeng K., Er P.N., et al. Hepatocyte encapsulation for enhanced cellular functions. Tissue Eng 6 5 (2000) 481-495
22. Seglen P.O. Preparation of isolated rat liver cells. Methods Cell Biol 13 (1976) 29-83
23. Bhatia S.N., Balis U.J., Yarmush M.L., and Toner M. Effect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells. FASEB J 13 14 (1999) 1883-1900
24. Kuri-Harcuch W., and Mendoza-Figueroa T. Cultivation of adult rat hepatocytes on 3T3 cells: expression of various liver differentiated functions. Differentiation 41 2 (1989) 148-157
25. Bhatia S.N., Balis U.J., Yarmush M.L., and Toner M. Probing heterotypic cell interactions: hepatocyte function in microfabricated co-cultures. J Biomater Sci Polym Ed 9 11 (1998) 1137-1160
26. Nishikawa M., Kojima N., Komori K., Yamamoto T., Fujii T., and Sakai Y. Enhanced maintenance and functions of rat hepatocytes induced by combination of on-site oxygenation and coculture with fibroblasts. J Biotechnol 133 2 (2008) 253-260
27. Lu H.F., Chua K.N., Zhang P.C., Lim W.S., Ramakrishna S., Leong K.W., et al. Three-dimensional co-culture of rat hepatocyte spheroids and NIH/3T3 fibroblasts enhances hepatocyte functional maintenance. Acta Biomater 1 4 (2005) 399-410
28. Stevens M.M., and George J.H. Exploring and engineering the cell surface interface. Science 310 5751 (2005) 1135-1138
29. Takehara N., Tsutsumi Y., Tateishi K., Ogata T., Tanaka H., Ueyama T., et al. Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. J Am Coll Cardiol 52 23 (2008) 1858-1865
30. Patel Z.S., Ueda H., Yamamoto M., Tabata Y., and Mikos A.G. In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds. Pharm Res 25 10 (2008) 2370-2378
31. Beuth J. Proteolytic enzyme therapy in evidence-based complementary oncology: fact or fiction?. Integr Cancer Ther 7 4 (2008) 311-316
32. Sodunke T.R., Bouchard M.J., and Noh H.M. Microfluidic platform for hepatitis B viral replication study. Biomed Microdevices 10 3 (2008) 393-402
33. Sauer I.M., Obermeyer N., Kardassis D., Theruvath T., and Gerlach J.C. Development of a hybrid liver support system. Ann N Y Acad Sci 944 (2001) 308-319
34. Koike M., Matsushita M., Taguchi K., and Uchino J. Function of culturing monolayer hepatocytes by collagen gel coating and coculture with nonparenchymal cells. Artif Organs 20 2 (1996) 186-192